June 30, 2025 - 17:12

Boeing Co. has confirmed that Chief Financial Officer Brian West will be stepping down from his position. West played a pivotal role in orchestrating one of the largest capital raises in U.S. corporate history last year, a move aimed at stabilizing the company amid ongoing challenges. His departure comes at a critical time for Boeing, which has faced numerous hurdles, including production issues and regulatory scrutiny.
The company has announced that it will appoint a new CFO, drawing from experienced leadership in the aerospace sector. The former finance chief of Lockheed Martin is set to take over, bringing a wealth of experience in managing finances within the defense and aerospace industries. This leadership change is seen as a strategic move to enhance Boeing's financial stability and restore investor confidence.
As the company navigates through its recovery phase, the transition in leadership is expected to play a significant role in shaping Boeing's future direction and operational efficiency.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...